228 related articles for article (PubMed ID: 25870375)
1. A novel approach using sorafenib in alpha fetoprotein-producing hepatoid adenocarcinoma of the lung.
Gavrancic T; Park YH
J Natl Compr Canc Netw; 2015 Apr; 13(4):387-91; quiz 391. PubMed ID: 25870375
[TBL] [Abstract][Full Text] [Related]
2. Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report.
Xu SZ; Zhang XC; Jiang Q; Chen M; He MY; Shen P
World J Clin Cases; 2022 Oct; 10(28):10236-10243. PubMed ID: 36246828
[TBL] [Abstract][Full Text] [Related]
3. A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805).
Zhou Q; Zhou CC; Chen GY; Cheng Y; Huang C; Zhang L; Xu CR; Li AW; Yan HH; Su J; Zhang XC; Yang JJ; Wu YL
Lung Cancer; 2014 Mar; 83(3):369-73. PubMed ID: 24440279
[TBL] [Abstract][Full Text] [Related]
4. Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.
Lin J; Cao Y; Yu L; Lin L
Medicine (Baltimore); 2018 Sep; 97(39):e12336. PubMed ID: 30278510
[TBL] [Abstract][Full Text] [Related]
5. AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report.
Chiba N; Yoshioka T; Sakayori M; Mikami Y; Miyazaki S; Akiyama S; Otsuka K; Yamaura G; Shibata H; Kato S; Kato S; Ishioka C
Anticancer Res; 2005; 25(4):2965-8. PubMed ID: 16080552
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute.
Hainsworth JD; Thompson DS; Bismayer JA; Gian VG; Merritt WM; Whorf RC; Finney LH; Dudley BS
Cancer Med; 2015 May; 4(5):673-81. PubMed ID: 25556916
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of sorafenib in patients with platinum-pretreated, advanced (Stage IIIb or IV) non-small cell lung cancer with a KRAS mutation.
Dingemans AM; Mellema WW; Groen HJ; van Wijk A; Burgers SA; Kunst PW; Thunnissen E; Heideman DA; Smit EF
Clin Cancer Res; 2013 Feb; 19(3):743-51. PubMed ID: 23224737
[TBL] [Abstract][Full Text] [Related]
8. A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806).
Lim SM; Cho BC; Kim SW; Kang SY; Heo DS; Kim HT; Lee DH; Kim DW; Jung M; Choi JH; Shim HS; Choi JR; Kim JH
Lung Cancer; 2016 Mar; 93():1-8. PubMed ID: 26898607
[TBL] [Abstract][Full Text] [Related]
9. Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report.
Nakao S; Nakata B; Tendo M; Kuroda K; Hori T; Inaba M; Hirakawa K; Ishikawa T
BMC Surg; 2015 Jan; 15(1):5. PubMed ID: 25591731
[TBL] [Abstract][Full Text] [Related]
10. Synchronous presentation of hepatoid alpha-fetoprotein-producing lung cancer and colorectal adenocarcinoma.
Valentino F; Torchio M; Morbini P; Danova M
Tumori; 2012; 98(5):130e-134e. PubMed ID: 23235768
[TBL] [Abstract][Full Text] [Related]
11. Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer.
Scagliotti G; Novello S; von Pawel J; Reck M; Pereira JR; Thomas M; Abrão Miziara JE; Balint B; De Marinis F; Keller A; Arén O; Csollak M; Albert I; Barrios CH; Grossi F; Krzakowski M; Cupit L; Cihon F; Dimatteo S; Hanna N
J Clin Oncol; 2010 Apr; 28(11):1835-42. PubMed ID: 20212250
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein producing Barrett's esophageal adenocarcinoma: a case report.
Shimakawa T; Ogawa K; Naritaka Y; Wagatsuma Y; Katsube T; Hamaguchi K; Konno S; Aiba M; Kajiwara T
Anticancer Res; 1999; 19(5C):4369-73. PubMed ID: 10650778
[TBL] [Abstract][Full Text] [Related]
13. Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.
Itokawa N; Atsukawa M; Tsubota A; Okubo T; Arai T; Nakagawa A; Kondo C; Iwakiri K
Int J Clin Oncol; 2016 Aug; 21(4):676-683. PubMed ID: 26701173
[TBL] [Abstract][Full Text] [Related]
14. [Alpha Fetoprotein-producing Lung Adenocarcinoma].
Komori K; Tabata T; Sato K; Katsumata H; Minowa M; Kondo T
Kyobu Geka; 2015 Nov; 68(12):995-9. PubMed ID: 26555914
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization.
Liu L; Zhao Y; Jia J; Chen H; Bai W; Yang M; Yin Z; He C; Zhang L; Guo W; Niu J; Yuan J; Cai H; Xia J; Fan D; Han G
Sci Rep; 2016 Feb; 6():19851. PubMed ID: 26831408
[TBL] [Abstract][Full Text] [Related]
16. A case report of a three-year survivor with advanced non-small cell lung cancer producing alpha-fetoprotein.
Tamura T; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Sano T; Keicho N; Morinaga S
Jpn J Clin Oncol; 1986 Jun; 16(2):175-81. PubMed ID: 2426481
[TBL] [Abstract][Full Text] [Related]
17. Hepatoid adenocarcinoma of the lung and the review of the literature.
Tonyali O; Gonullu O; Ozturk MA; Kosif A; Civi OG
J Oncol Pharm Pract; 2020 Sep; 26(6):1505-1510. PubMed ID: 32041468
[TBL] [Abstract][Full Text] [Related]
18. Hepatoid adenocarcinoma of the lung: Review of a rare form of lung cancer.
Grossman K; Beasley MB; Braman SS
Respir Med; 2016 Oct; 119():175-179. PubMed ID: 27692141
[TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
Wang YK; Shen L; Jiao X; Zhang XT
World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
[TBL] [Abstract][Full Text] [Related]
20. Α-fetoprotein producing hepatoid gastric adenocarcinoma with neuroendocrine differentiation: A case report.
Li T; Liu T; Wang M; Zhang M
Medicine (Baltimore); 2018 Sep; 97(37):e12359. PubMed ID: 30212993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
